Comprehensive intravascular imaging of atherosclerotic plaque in vivo using optical coherence tomography and fluorescence lifetime imaging

Min Woo Lee, Joon Woo Song, Woo Jae Kang, Hyeong Soo Nam, Tae Shik Kim, Sunwon Kim, Wang-Yuhl Oh, Jin Won Kim, Hongki Yoo, Min Woo Lee, Joon Woo Song, Woo Jae Kang, Hyeong Soo Nam, Tae Shik Kim, Sunwon Kim, Wang-Yuhl Oh, Jin Won Kim, Hongki Yoo

Abstract

Comprehensive imaging of both the structural and biochemical characteristics of atherosclerotic plaque is essential for the diagnosis and study of coronary artery disease because both a plaque's morphology and its biochemical composition affect the level of risk it poses. Optical coherence tomography (OCT) and fluorescence lifetime imaging (FLIm) are promising optical imaging methods for characterizing coronary artery plaques morphologically and biochemically, respectively. In this study, we present a hybrid intravascular imaging device, including a custom-built OCT/FLIm system, a hybrid optical rotary joint, and an imaging catheter, to visualize the structure and biochemical composition of the plaque in an atherosclerotic rabbit artery in vivo. Especially, the autofluorescence lifetime of the endogenous tissue molecules can be used to characterize the biochemical composition; thus no exogenous contrast agent is required. Also, the physical properties of the imaging catheter and the imaging procedures are similar to those already used clinically, facilitating rapid translation into clinical use. This new intravascular imaging catheter can open up new opportunities for clinicians and researchers to investigate and diagnose coronary artery disease by simultaneously providing tissue microstructure and biochemical composition data in vivo without the use of exogenous contrast agent.

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Schematic diagram of the fully integrated IV-OCT/FLIm system for structural and biochemical imaging simultaneously. IV-OCT/FLIm system consisted of OCT subsystem (yellow), FLIm subsystem (red), an intravascular imaging part (green) and data acquisition and display part (light orange). Black, purple, blue, green and red solid lines: optical fiber; gray solid lines: electric wire for transferring data; gray dashed lines: electrical wire for triggering; IRF: instrument response function; Ch1: channel 1; Ch2: channel 2; Ch3: channel 3.
Figure 2
Figure 2
Optical rotary joint (ORJ) and multimodal imaging catheter. (a) Schematic diagram and photograph of ORJ. L, lens; DM, dichroic mirror; SMF, single-mode fiber; MMF, multi-mode fiber; DCF, double-clad fiber. (b) Photograph of multimodal imaging catheter with a 1 cent coin. The outer diameter of the imaging sheath is 1.04 mm. (c) Intensity plot without (dark gray) and with (gray) imaging window and transmittance plot (black) of imaging window. Transmittance of imaging window is more than 75% at OCT and FLIm light.
Figure 3
Figure 3
Phantom experiment validating the co-registration between OCT and FLIm. (a) Schematic diagram of the phantom consisting of glass tubes filled with milk and standard fluorophores. (b) Representative cross-sectional image of phantom. Grayscale and pseudo color represent OCT image and fluorescence lifetime, respectively. (c) Intensity graph of OCT and fluorescence along the rotational angle. (d) OCT enface map of maximum projection. The two-dimensional fluorescence lifetime maps obtained from channel (e) 1, (f) 2, and (g) 3. Scale bar: 1 mm.
Figure 4
Figure 4
In vivo OCT/FLIm imaging results in a rabbit aorta. (a) Longitudinal OCT/FLIm images of a rabbit aorta. Grayscale and pseudo color represent the OCT image and fluorescence lifetime, respectively. (b) Representative cross-sectional image of normal aorta. Structures of normal aorta, including media (M) and adventitia (A) are clearly visible. (c) Representative cross-sectional image of atherosclerotic plaque. It shows lipid-rich plaque with thickened media and diffuse borer (yellow arrowheads) suggesting presence of lipid in OCT, and it also contains normal area (red arrowheads). (d) 3D rendering longitudinal cut-view image. The fluorescence lifetime is overlaid on the luminal surface of the OCT 3D rendering. The fluorescence lifetime in (ad) was measured on channel 2. The 2D fluorescence lifetime maps measured on channel (e) 1, (f) 2, and (g) 3. The horizontal and vertical directions are the pullback direction and rotational direction, respectively. (h) Comparison of the averaged fluorescence lifetime between the normal aorta and atherosclerotic plaque. Results are presented as means ± standard deviation. *P < 0.001, by unpaired t-test. Scale bars: 1 mm. M, media; A, adventitia.
Figure 5
Figure 5
Histopathological staining and cross-sectional OCT/FLIm images of (ad) normal aorta and (eh) atherosclerotic plaque. (a, e) Oil red O (ORO) stained tissue that represents lipids (red color). (b,f) Immunohistochemistry with RAM 11 antibody (brown color) that represents macrophages. (c,g) Picrosirius red (PSR) stained tissue that represents collagen types I (yellow-orange birefringence) and III (green birefringence). (d,h) Cross-sectional OCT/FLIm images of rabbit aorta. Intensity-weighted fluorescence lifetime is expressed as rings from channels 1, 2 and 3 (in turn from inner to outer) outside the OCT images. Morphological landmarks, such as side branch (red arrows) and plaque shape (red asterisks), show the match between the histopathological sections and the in vivo OCT/FLIm cross-sectional images. Fluorescence lifetime colormap is the same as given in Fig. 4. Scale bars: 1 mm.

References

    1. Benjamin EJ, et al. Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association. Circulation. 2017;135:E146–E603. doi: 10.1161/CIR.0000000000000485.
    1. Stefanadis C., Antoniou C. K., Tsiachris D., Pietri P. Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives. J Am Heart Assoc6 (2017).
    1. Kolodgie FD, et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol. 2001;16:285–292. doi: 10.1097/00001573-200109000-00006.
    1. Kume T, et al. Frequency and spatial distribution of thin-cap fibroatheroma assessed by 3-vessel intravascular ultrasound and optical coherence tomography: an ex vivo validation and an initial in vivo feasibility study. Circ J. 2009;73:1086–1091. doi: 10.1253/circj.CJ-08-0733.
    1. Prati F, et al. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J. 2010;31:401–415. doi: 10.1093/eurheartj/ehp433.
    1. Rathod KS, Hamshere SM, Jones DA, Mathur A. Intravascular ultrasound versus optical coherence tomography for coronary artery imaging–Apples and oranges. Interventional Cardiology Review. 2015;10:8–15. doi: 10.15420/icr.2015.10.1.8.
    1. Garcia-Garcia HM, Gogas BD, Serruys PW, Bruining N. IVUS-based imaging modalities for tissue characterization: similarities and differences. Int J Cardiovas Imag. 2011;27:215–224. doi: 10.1007/s10554-010-9789-7.
    1. Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circulation research. 1992;71:850–858. doi: 10.1161/01.RES.71.4.850.
    1. Li Z-Y, et al. Stress analysis of carotid plaque rupture based on in vivo high resolution MRI. Journal of biomechanics. 2006;39:2611–2622. doi: 10.1016/j.jbiomech.2005.08.022.
    1. Li ZY, Howarth SPS, Tang T, Gillard JH. How critical is fibrous cap thickness to carotid plaque stability? A flow-plaque interaction model. Stroke. 2006;37:1195–1199. doi: 10.1161/01.STR.0000217331.61083.3b.
    1. Roleder T, et al. The basics of intravascular optical coherence tomography. Postep Kardiol Inter. 2015;11:74–83.
    1. Bourantas CV, et al. Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology. Eur Heart J. 2017;38:400–U432. doi: 10.1093/eurheartj/ehw097.
    1. Madder RD, Steinberg DH, Anderson RD. Multimodality direct coronary imaging with combined near-infrared spectroscopy and intravascular ultrasound: Initial US experience. Catheter Cardio Inte. 2013;81:551–557. doi: 10.1002/ccd.23358.
    1. Kang SJ, et al. Combined IVUS and NIRS Detection of Fibroatheromas Histopathological Validation in Human Coronary Arteries. Jacc-Cardiovasc Imag. 2015;8:184–194. doi: 10.1016/j.jcmg.2014.09.021.
    1. Yoo H, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med. 2011;17:1680–1684. doi: 10.1038/nm.2555.
    1. Lee S, et al. Fully integrated high-speed intravascular optical coherence tomography/near-infrared fluorescence structural/molecular imaging in vivo using a clinically available near-infrared fluorescence-emitting indocyanine green to detect inflamed lipid-rich atheromata in coronary-sized vessels. Circ Cardiovasc Interv. 2014;7:560–569. doi: 10.1161/CIRCINTERVENTIONS.114.001498.
    1. Kim J. B. et al. Intravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors. Sci Rep-Uk6, (2016).
    1. Kim S, et al. Intracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural-molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-associated inflammation in a beating coronary artery. Eur Heart J. 2016;37:2833–2844. doi: 10.1093/eurheartj/ehv726.
    1. Wang H, et al. Ex vivo catheter-based imaging of coronary atherosclerosis using multimodality OCT and NIRAF excited at 633 nm. Biomed Opt Express. 2015;6:1363–1375. doi: 10.1364/BOE.6.001363.
    1. Ughi GJ, et al. Clinical Characterization of Coronary Atherosclerosis With Dual-Modality OCT and Near-Infrared Autofluorescence Imaging. JACC Cardiovasc Imaging. 2016;9:1304–1314. doi: 10.1016/j.jcmg.2015.11.020.
    1. Hara T, et al. Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo. Eur Heart J. 2017;38:447–455.
    1. Ughi GJ, et al. Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging. Int J Cardiovasc Imaging. 2015;31:259–268. doi: 10.1007/s10554-014-0556-z.
    1. Elson DS, Jo JA, Marcu L. Miniaturized side-viewing imaging probe for fluorescence lifetime imaging (FLIM): validation with fluorescence dyes, tissue structural proteins and tissue specimens. New J Phys. 2007;9:127. doi: 10.1088/1367-2630/9/5/127.
    1. Marcu L. Fluorescence lifetime in cardiovascular diagnostics. J Biomed Opt. 2010;15:011106. doi: 10.1117/1.3327279.
    1. Park J, et al. Biochemical characterization of atherosclerotic plaques by endogenous multispectral fluorescence lifetime imaging microscopy. Atherosclerosis. 2012;220:394–401. doi: 10.1016/j.atherosclerosis.2011.10.034.
    1. Bec J, et al. Design, construction, and validation of a rotary multifunctional intravascular diagnostic catheter combining multispectral fluorescence lifetime imaging and intravascular ultrasound. J Biomed Opt. 2012;17:106012. doi: 10.1117/1.JBO.17.10.106012.
    1. Ma D, et al. Rotational multispectral fluorescence lifetime imaging and intravascular ultrasound: bimodal system for intravascular applications. J Biomed Opt. 2014;19:066004. doi: 10.1117/1.JBO.19.6.066004.
    1. Bec J, et al. Multispectral fluorescence lifetime imaging system for intravascular diagnostics with ultrasound guidance: in vivo validation in swine arteries. J Biophotonics. 2014;7:281–285. doi: 10.1002/jbio.201200220.
    1. Yankelevich DR, et al. Design and evaluation of a device for fast multispectral time-resolved fluorescence spectroscopy and imaging. Rev Sci Instrum. 2014;85:034303. doi: 10.1063/1.4869037.
    1. Park J, et al. A dual-modality optical coherence tomography and fluorescence lifetime imaging microscopy system for simultaneous morphological and biochemical tissue characterization. Biomed Opt Express. 2010;1:186–200. doi: 10.1364/BOE.1.000186.
    1. Bec J. et al. In-vivo validation of fluorescence lifetime imaging (FLIm) of coronary arteries in swine. In: SPIE BiOS (ed^(eds). International Society for Optics and Photonics (2015).
    1. Fatakdawala H, et al. Fluorescence Lifetime Imaging Combined with Conventional Intravascular Ultrasound for Enhanced Assessment of Atherosclerotic Plaques: an Ex Vivo Study in Human Coronary Arteries. J Cardiovasc Transl Res. 2015;8:253–263. doi: 10.1007/s12265-015-9627-3.
    1. Jo JA, et al. Simultaneous morphological and biochemical endogenous optical imaging of atherosclerosis. Eur Heart J Cardiovasc Imaging. 2015;16:910–918. doi: 10.1093/ehjci/jev018.
    1. Sherlock BE, Phipps JE, Bec J, Marcu L. Simultaneous, label-free, multispectral fluorescence lifetime imaging and optical coherence tomography using a double-clad fiber. Opt Lett. 2017;42:3753–3756. doi: 10.1364/OL.42.003753.
    1. Kim W, Chen X, Jo JA, Applegate BE. Lensless, ultra-wideband fiber optic rotary joint for biomedical applications. Opt Lett. 2016;41:1973–1976. doi: 10.1364/OL.41.001973.
    1. Nam HS, et al. Multispectral analog-mean-delay fluorescence lifetime imaging combined with optical coherence tomography. Biomed Opt Express. 2018;9:1930–1947. doi: 10.1364/BOE.9.001930.
    1. Won YJ, Han WT, Kim DY. Precision and accuracy of the analog mean-delay method for high-speed fluorescence lifetime measurement. J Opt Soc Am A Opt Image Sci Vis. 2011;28:2026–2032. doi: 10.1364/JOSAA.28.002026.
    1. Won Y, et al. High-speed confocal fluorescence lifetime imaging microscopy (FLIM) with the analog mean delay (AMD) method. Opt Express. 2011;19:3396–3405. doi: 10.1364/OE.19.003396.
    1. Moon S, Won Y, Kim DY. Analog mean-delay method for high-speed fluorescence lifetime measurement. Opt Express. 2009;17:2834–2849. doi: 10.1364/OE.17.002834.
    1. Bouma BE, Villiger M, Otsuka K, Oh WY. Intravascular optical coherence tomography [Invited] Biomed Opt Express. 2017;8:2660–2686. doi: 10.1364/BOE.8.002660.
    1. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv. 2009;2:1035–1046. doi: 10.1016/j.jcin.2009.06.019.
    1. Kim S, et al. Coronary stent fracture complicated multiple aneurysms confirmed by 3-dimensional reconstruction of intravascular-optical coherence tomography in a patient treated with open-cell designed drug-eluting stent. Circulation. 2014;129:e24–27. doi: 10.1161/CIRCULATIONAHA.112.000223.
    1. Lee S, Kim CS, Oh DJ, Yoo H, Kim JW. Three-dimensional intravascular optical coherence tomography rendering assessment of spontaneous coronary artery dissection concomitant with left main ostial critical stenosis. JACC Cardiovasc Interv. 2014;7:e57–59. doi: 10.1016/j.jcin.2013.10.023.
    1. Pal H, Nad S, Kumbhakar M. Photophysical properties of coumarin-120: Unusual behavior in nonpolar solvents. The Journal of chemical physics. 2003;119:443–452. doi: 10.1063/1.1578057.
    1. Magde D, Rojas GE, Seybold PG. Solvent dependence of the fluorescence lifetimes of xanthene dyes. Photochemistry and Photobiology. 1999;70:737–744. doi: 10.1111/j.1751-1097.1999.tb08277.x.
    1. Fujimoto JG, et al. High resolution in vivo intra-arterial imaging with optical coherence tomography. Heart. 1999;82:128–133. doi: 10.1136/hrt.82.2.128.
    1. Tearney GJ, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59:1058–1072. doi: 10.1016/j.jacc.2011.09.079.
    1. Alfonso-Garcia A, et al. Label-free identification of macrophage phenotype by fluorescence lifetime imaging microscopy. J Biomed Opt. 2016;21:46005. doi: 10.1117/1.JBO.21.4.046005.
    1. Farand P, Garon A, Plante GE. Structure of large arteries: orientation of elastin in rabbit aortic internal elastic lamina and in the elastic lamellae of aortic media. Microvascular research. 2007;73:95–99. doi: 10.1016/j.mvr.2006.10.005.
    1. Kanshana JS, et al. Progression and Characterization of the Accelerated Atherosclerosis in Iliac Artery of New Zealand White Rabbits: Effect of Simvastatin. Journal of cardiovascular pharmacology. 2017;69:314–325. doi: 10.1097/FJC.0000000000000477.
    1. Phipps J, Sun Y, Saroufeem R, Hatami N, Marcu L. Fluorescence lifetime imaging microscopy for the characterization of atherosclerotic plaques. Proc SPIE Int Soc Opt Eng. 2009;7161:71612G.
    1. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med. 2009;14:73–89. doi: 10.1177/1358863X08094801.
    1. Rekhter MD. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovascular research. 1999;41:376–384. doi: 10.1016/S0008-6363(98)00321-6.
    1. Phipps J, et al. Fluorescence lifetime imaging for the characterization of the biochemical composition of atherosclerotic plaques. J Biomed Opt. 2011;16:096018. doi: 10.1117/1.3626865.
    1. Cho HS, et al. High frame-rate intravascular optical frequency-domain imaging in vivo. Biomed Opt Express. 2013;5:223–232. doi: 10.1364/BOE.5.000223.
    1. Patrick H, Gilbert SL, Lidgard A. Decrease of fluorescence in optical fiber during exposure to pulsed or continuous-wave ultraviolet light. Optical Materials. 1994;3:209–216. doi: 10.1016/0925-3467(94)90006-X.
    1. Noguchi K, Uesugi N, Suzuki K. Visible-region optical absorption property for germanium-doped silica optical fibres induced by UV light propagation. Electronics Letters. 1986;22:519–520. doi: 10.1049/el:19860353.
    1. Bec J, et al. In vivo label-free structural and biochemical imaging of coronary arteries using an integrated ultrasound and multispectral fluorescence lifetime catheter system. Sci Rep. 2017;7:8960. doi: 10.1038/s41598-017-08056-0.
    1. Ozaki Y, et al. Comparison of contrast media and low-molecular-weight dextran for frequency-domain optical coherence tomography. Circ J. 2012;76:922–927. doi: 10.1253/circj.CJ-11-1122.
    1. Elson D, et al. Time-domain fluorescence lifetime imaging applied to biological tissue. Photochem Photobiol Sci. 2004;3:795–801. doi: 10.1039/b316456j.
    1. Hage CH, et al. Towards two-photon excited endogenous fluorescence lifetime imaging microendoscopy. Biomed Opt Express. 2018;9:142–156. doi: 10.1364/BOE.9.000142.
    1. Marcu L, Fishbein MC, Maarek JM, Grundfest WS. Discrimination of human coronary artery atherosclerotic lipid-rich lesions by time-resolved laser-induced fluorescence spectroscopy. Arteriosclerosis, thrombosis, and vascular biology. 2001;21:1244–1250. doi: 10.1161/hq0701.092091.
    1. Phipps JE, Sun Y, Fishbein MC, Marcu L. A fluorescence lifetime imaging classification method to investigate the collagen to lipid ratio in fibrous caps of atherosclerotic plaque. Lasers Surg Med. 2012;44:564–571. doi: 10.1002/lsm.22059.
    1. Freestone T, Turner RJ, Higman DJ, Lever MJ, Powell JT. Influence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysm in rabbits. Arteriosclerosis, thrombosis, and vascular biology. 1997;17:10–17. doi: 10.1161/01.ATV.17.1.10.
    1. Bi Y, et al. Novel experimental model of enlarging abdominal aortic aneurysm in rabbits. Journal of vascular surgery. 2015;62:1054–1063. doi: 10.1016/j.jvs.2014.02.062.
    1. Phinikaridou A, Hallock KJ, Qiao Y, Hamilton JA. A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res. 2009;50:787–797. doi: 10.1194/jlr.M800460-JLR200.
    1. Reimann C, et al. Molecular imaging of the extracellular matrix in the context of atherosclerosis. Adv Drug Deliv Rev. 2017;113:49–60. doi: 10.1016/j.addr.2016.09.005.
    1. Douglas GR, et al. Impact of Fiber Structure on the Material Stability and Rupture Mechanisms of Coronary Atherosclerotic Plaques. Ann Biomed Eng. 2017;45:1462–1474. doi: 10.1007/s10439-017-1827-3.
    1. Marcu L, et al. Detection of rupture-prone atherosclerotic plaques by time-resolved laser-induced fluorescence spectroscopy. Atherosclerosis. 2009;204:156–164. doi: 10.1016/j.atherosclerosis.2008.08.035.
    1. Marcu L, et al. In vivo detection of macrophages in a rabbit atherosclerotic model by time-resolved laser-induced fluorescence spectroscopy. Atherosclerosis. 2005;181:295–303. doi: 10.1016/j.atherosclerosis.2005.02.010.

Source: PubMed

3
订阅